SNGX Stock | News | Quote | Stock Forum | Tuesday, October 29,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Soligenix, Inc. SNGX Company Overview 

Soligenix, Inc. SNGX Current Price and Quotes
Last Price 2.03
Previous Close 2.01 Open 2.04
Daily Range 2.04 - 1.91 52wk Range 2.48 - 0.43
Volume 58,129 Dividend N/A
Average Vol (3m) 82,282 Yield N/A

SNGX Stock Message Board http://investorshangout.com/search?q=SNGX&...mp;yt1=Go!

Last Updated: Tuesday, October 29, 2013 02:31:58 AM

Soligenix, Inc. SNGX
Company Information

29 Emmons Drive
Suite C-10
Princeton, NJ 08540

Website: http://www.soligenix.com
Phone: 609-538-8200

Soligenix, Inc. SNGX
Soligenix, Inc. is a development stage biopharmaceutical company committed to developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and Graft-versus-Host dis...



Soligenix, Inc. SNGX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000812796
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Jun 10, 2013
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Christopher J. Schaber President, CEO
Joseph M. Warusz Vice President, Acting CFO, Principal Acct. Officer
Company Directors

Keith Brownlie
Gregg Lapointe
Robert Rubin
Jerome Zeldis
Company Notes

Formerly=DOR BioPharma, Inc. until 9-2009
Formerly=Endorex Corp. until 12-01
Formerly=ImmunoTherapeutics, Inc. until 9-96
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Soligenix, Inc. SNGX
SNGX Security Details

Share Structure

Market Value1 $38,631,889 a/o Oct 28, 2013
Shares Outstanding 19,030,487 a/o Aug 07, 2013
Float Not Available
Authorized Shares 50,000,000 a/o Jun 07, 2013
Par Value  0.001
Shareholders

Shareholders of Record 940 a/o Feb 26, 2013
Security Notes

New Issue=6-87 500,000 shs in units (1 sh Com & 1 Class A Warr 7-31-92) at $4 per unit by Seaboard Planning Corp.
Note=4-18-06 deleted from AMEX
Capital Change=shs decreased by 1 for 15 split Pay date=06/11/1997.
Capital Change=shs decreased by 1 for 20 split. Pay date=02/01/2012.
Short Selling Data

Short Interest 358,964 (3.8%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

American Stock Transfer & Trust Company

Soligenix, Inc. SNGX Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 3,145 7,663 1,948 2,816
Cost of Revenue 2,593 2,108 1,638 1,484
Gross Profit 552 5,555 309 1,332
Operating Expenses

Research and Development 2,609 6,273 5,986 4,523
Sales, General and Admin. 2,633 2,242 2,201 2,860
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,691) (2,960) (7,878) (6,051)
Income From Continuing Operations

Add'l Income/Expense Items 6 7 247 20
Earnings Before Interest and Tax (4,684) (2,953) (7,632) (6,032)
Interest Expense - - 1 3
Earnings Before Tax (4,684) (2,953) (7,632) (6,034)
Income Tax (521) (574) (246) -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,163) (2,379) (7,387) (6,034)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,163) (2,379) (7,387) (6,034)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,163) (2,379) (7,387) (6,034)

Soligenix, Inc. SNGX Recent News

Oct 28, 2013 Soligenix to Host Conference Call and Webcast Discussion on Oral Mucositis
Oct 21, 2013 Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
Oct 17, 2013 Soligenix Announces Formation of International Melioidosis Scientific Advisory Board
Oct 3, 2013 Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
Sep 25, 2013 Soligenix Awarded NIAID Contract Valued up to $6.4 Million for the Development of OrbeShield(TM) in GI ARS
Sep 19, 2013 Soligenix Awarded BARDA Contract Valued up to $26.3 Million for Advanced Development of OrbeShield(TM) in GI ARS
Sep 16, 2013 FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
Sep 5, 2013 Soligenix to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
Aug 12, 2013 Soligenix Reports Second Quarter 2013 Financial Results, and Highlights Recent Accomplishments


SNGX Soligenix, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=SNGX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SNGX/quote
Stock Chart http://www.otcmarkets.com/stock/SNGX/chart
Company Info http://www.otcmarkets.com/stock/SNGX/company-info
Recent News http://www.otcmarkets.com/stock/SNGX/news
Financials http://www.otcmarkets.com/stock/SNGX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SNGX/filings
Short Sales http://www.otcmarkets.com/stock/SNGX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SNGX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SNGX/research
Summary http://finance.yahoo.com/q?s=SNGX
Historical Prices http://finance.yahoo.com/q/hp?s=SNGX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SNGX
Basic Chart http://finance.yahoo.com/q/bc?s=SNGX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SNGX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SNGX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SNGX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SNGX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SNGX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SNGX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SNGX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SNGX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SNGX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SNGX
Balance Sheet http://finance.yahoo.com/q/bs?s=SNGX
Cash Flow http://finance.yahoo.com/q/cf?s=SNGX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SNGX
Market Watch http://www.marketwatch.com/investing/stock/SNGX
Bloomberg http://www.bloomberg.com/quote/SNGX:US
Morningstar http://quotes.morningstar.com/stock/s?t=SNGX
Bussinessweek http://investing.businessweek.com/research/st...icker=SNGX
Barchart http://www.barchart.com/quotes/stocks/SNGX
OTC Short Report http://otcshortreport.com/index.php?index=SNGX
Investopedia http://www.investopedia.com/markets/stocks/SNGX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 87

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 84

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 170

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory

Updated Category News Views 84

Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 128

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 98

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 64

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 94

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading